Long-Term Health of Children with Congenital CMV in NY
Part of Brain & nervous system, Ear, nose & throat, Infections clinical trials.
This study will follow children born in New York State who were tested for cytomegalovirus (CMV) as newborns. It aims to understand their long-term health and development, whether they were confirmed to have CMV, a false positive, or even a late detection if born early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born in New York State during a special CMV screening pilot program (September 2023 to October 2024).
- Your baby had a CMV evaluation at a designated New York State CMV clinic.
- Your family is willing and able to take part in all parts of this long-term study.
- Your baby's CMV status (positive or negative) was confirmed by specific tests, and they fit into one of four categories described by the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study examines blood samples from newborns to identify biological markers (proteins and genetic signals) that could help detect and understand congenital cytomegalovirus (CMV) infection—a virus some babies are born with. Finding these markers might help doctors identify infected infants earlier and develop better treatments.
This study tests if giving antiviral medicine for 4 to 6 months helps babies born with cytomegalovirus (CMV) infection that affects their brain and development. It aims to see if longer treatment can prevent problems like hearing loss or delayed growth.
This Phase 2 study monitors how your immune system reacts to CMV (a common virus) after a lung transplant. It may help doctors understand which patients are better protected and could guide future treatments to reduce CMV-related complications.
This study checks if babies who fail their newborn hearing test might have a hidden infection from birth. It looks for cytomegalovirus (CMV), a common virus that can affect hearing, using a simple test.
This is an observational study that looks at how babies with congenital CMV infection are diagnosed and managed in real life. It may help doctors understand which care approaches are used and how they relate to outcomes over time.
This Phase 2 trial tests an immune treatment made from donor T-cells to help the body fight congenital CMV infection in newborns. It may be an option if your baby is very young, has evidence of CMV infection, and meets specific blood, kidney, and liver safety limits.
Hear when a new Congenital CMV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.